Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Abdullah Evren, Yetisir"'
Autor:
Cem MIRILI, Semra PAYDAS, Mahmut BUYUKSIMSEK, Mert TOHUMCUOĞLU, Abdullah Evren YETISIR, Ali OGUL
Publikováno v:
Namık Kemal Tıp Dergisi, Vol 7, Iss 3, Pp 271-278 (2019)
Aim:fSoft tissue sarcomas (STSs) account for 1% of cancers in the adult population. The treatment of choice is surgery but chemotherapy and/or radiotherapy are frequently used due to aggressive cancer behavior or incomplete surgery. Doxorubicin-based
Externí odkaz:
https://doaj.org/article/23346dd820e14da8beb87db1e8c11283
Autor:
Abdullah Evren Yetisir, Semra Paydas
Publikováno v:
Namık Kemal Tıp Dergisi. 9:179-183
Aim: In our study, we aimed to determine the clinicopathological factors affecting the pathological response after neoadjuvant chemotherapy inHER2 positive breast cancer.Materials and Methods: A total of 54 HER2 expression positive cases were include
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6e5b56e69c4316c087033ca3cdf2fea0
https://doi.org/10.4274/nkmj.galenos.2021.32932
https://doi.org/10.4274/nkmj.galenos.2021.32932
Autor:
Mahmut Buyuksimsek, Ali Ogul, Abdullah Evren Yetisir, Berna Bozkurt Duman, Mert Tohumcuoglu, Timucin Cil, Tolga Koseci, Mehmet Mutlu Kidi, Hilmi Erdem Sumbul
Publikováno v:
Journal of Oncology Pharmacy Practice. :107815522311713
Introduction Brigatinib is a next-generation anaplastic lymphoma kinase (ALK) inhibitor that targets a wide variety of ALK mutations and ROS1 rearrangements. While pancreatic enzyme elevations due to brigatinib are well known, we wanted to present a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5ecebb533d19f21e7382eca6b4eafbbb
https://doi.org/10.1177/10781552231171322
https://doi.org/10.1177/10781552231171322
Autor:
Isa Burak Guney, Mahmut Büyükşimşek, Abdullah Evren Yetisir, Cem Mirili, İrem Kolsuz, Ali Ogul, Semra Paydas, Mert Tohumcuoglu
Publikováno v:
Turkish Journal of Hematology, Vol 37, Iss 4, Pp 220-225 (2020)
Turkish Journal of Hematology
Turkish Journal of Hematology
Bone marrow infiltration (BMI) affects the stage diagnosis, and treatment of lymphoma. We aimed to evaluate the performance of bone marrow biopsy (BMB) and positron emission tomography-computed tomography (PET/CT) in detecting BMI in lymphoma patient
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::223b523c53e36e92afa881e8048b0910
https://tjh.com.tr/jvi.aspx?pdir=tjh&plng=eng&un=TJH-39269&look4=
https://tjh.com.tr/jvi.aspx?pdir=tjh&plng=eng&un=TJH-39269&look4=
Autor:
Cem Mirili, Ali Oğul, Mert Tohumcuoğlu, Mahmut Buyuksimsek, Mustafa Toğun, Servet Başdoğan, Semra Paydas, Abdullah Evren Yetisir
Publikováno v:
Anadolu Kliniği Tıp Bilimleri Dergisi. 25:75-80
Amaç: Meme kanseri kadınlarda en sık görülen ve en sık ölüme neden olan kanserdir. Biz de merkezimizde takip ettiğimiz metastatik meme kanseri (MMK) olan hastaların klinik özelliklerini ve tedavi sonuçlarını araştırmak istedik. Gereç
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cf5b2c2715bf8a9567ae1f6f94da509e
https://doi.org/10.21673/anadoluklin.641856
https://doi.org/10.21673/anadoluklin.641856
Autor:
Huseyin Can Arbag, Hilmi Erdem Sumbul, Mahmut Buyuksimsek, Ali Ogul, Abdullah Evren Yetisir, Tolga Koseci, Berna Bozkurt Duman, Mert Tohumcuoglu, Oguzhan Kesen, Timucin Cil
Publikováno v:
Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.
Introduction The addition of panitumumab to chemotherapy in wild-type metastatic colon cancer contributes to survival. While the skin related side effects of panitumumab are well known, we wanted to present a case where it was a possible cause of acu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2cbc056936a9da909df234bdc6efffad
https://pubmed.ncbi.nlm.nih.gov/35037780
https://pubmed.ncbi.nlm.nih.gov/35037780
Autor:
Ali, Ogul, Semra, Paydas, Figen, Doran, Kivilcim Eren, Erdogan, Mert, Tohumcuoglu, Mahmut, Buyuksimsek, Cem, Mirili, Abdullah Evren, Yetisir
Publikováno v:
Journal of B.U.ON. : official journal of the Balkan Union of Oncology. 26(3)
There are no studies showing PRAME expression in stage II and III colon adenocarcinoma. In this study, we aimed to determine the frequency of PRAME expression and the relationship with survival and clinicopathological data in stage II and III colon a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::81b98283b1aebaa853ea0adb58d1b95e
https://pubmed.ncbi.nlm.nih.gov/34268964
https://pubmed.ncbi.nlm.nih.gov/34268964
Autor:
Cem Mirili, Mahmut Büyükşimşek, Ali Ogul, Abdullah Evren Yetisir, Ali Yilmaz, Semra Paydas, Mert Tohumcuoglu
Publikováno v:
Acta Oncologica Turcica. 52:372-378
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ba6d9eeda58b819e118c47e799b2f3d5
https://doi.org/10.5505/aot.2019.08760
https://doi.org/10.5505/aot.2019.08760
Publikováno v:
American journal of therapeutics.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ac6d2a139a2b824caba54b1deaef6599
https://pubmed.ncbi.nlm.nih.gov/34010162
https://pubmed.ncbi.nlm.nih.gov/34010162
Autor:
Cem Mirili, Mustafa Toğun, Semra Paydas, Ali Oğul, Mert Tohumcuoğlu, Abdullah Evren Yetisir, Mahmut Buyuksimsek
Publikováno v:
Namık Kemal Tıp Dergisi.
Amac: Kemoterapi sirasinda hepatit enfeksiyonu reaktivasyonu lenfoma hastalarinda onemli bir sorundur. Merkezimizde tedavi edilen lenfoma hastalarinda hepatit B virusu (HBV) ve hepatit C virusu (HCV) sikligini arastirmayi amacladik. Materyal ve Metot
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5a5fecb90ad890802e86fc61ca7a6cde
https://doi.org/10.37696/nkmj.632911
https://doi.org/10.37696/nkmj.632911